...
首页> 外文期刊>Future microbiology >Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic
【24h】

Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic

机译:Comprehensive review on molnupiravir in COVID-19: a novel promising antiviral to combat the pandemic

获取原文
获取原文并翻译 | 示例
           

摘要

Despite the progress in the management of COVID-19, effective oral antiviral agents are still lacking. In the present review, the potential beneficial effects of molnupiravir in the management of COVID-19 are discussed. A literature search in Google Scholar, Scopus, PubMed and clinicaltrials.gov for the relevant articles regarding the pharmacokinetics, pharmacodynamics and clinical trials of molnupiravir in the management of COVID-19 is conducted. Most of the preclinical studies and available clinical trials showed a favorable short-term safety profile of molnupiravir; however, given its possible genotoxic effects, further trials are required to confirm the long-term efficacy and safety of molnupiravir in patients with COVID-19.

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号